Artiva Biotherapeutics (ARTV) Shares Issued (2024 - 2025)

Artiva Biotherapeutics (ARTV) reported Shares Issued of $138000.0 for Q1 2025, down 99.92% quarter-over-quarter from $166.5 million in Q3 2024.

Artiva Biotherapeutics (ARTV) Shares Issued (2024 - 2025) Analysis & Trends

Artiva Biotherapeutics (ARTV) has 2 years of Shares Issued data on file, last reported at $138000.0 in Q1 2025.

Shares Issued for Q1 2025 came in at $138000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $138000.0 (down 99.92% YoY), and the FY2025 annual result was $138000.0, down 99.92% from the prior year.
Shares Issued eased to $138000.0 in Q1 2025 per ARTV's latest filing, from $166.5 million in the prior quarter.
Over five years, Shares Issued peaked at $166.5 million in Q3 2024 and troughed at $138000.0 in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	5.40 Mn
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	27.00 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	26,927.15
10	Artiva Biotherapeutics	241.85 Mn	241.85 Mn	-	-

Download Data